Overview

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study is looking at three seizure medicines. Patients with seizures are usually treated with phenytoin (Dilantin) or Fosphenytoin. These medicines can be given intravenously (IV)or by mouth. Another seizure medicine, levetiracetam (Keppra) can now be given this way also. This study will compare IV phenytoin (Dilantin) and IV fosphenytoin to levetiracetam (Keppra) in patients who have had a recent seizure. Only patients with a history of seizures can be involved. The patient must present to the emergency department within 4 hours of a seizure. The purpose of this study is to compare these three drugs, phenytoin (Dilantin), fosphenytoin, and levetiracetam (Keppra). The investigators are looking to see if these drugs can prevent another seizure in the next 24 hours. We are also looking for any possible side effects.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Emory University
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Fosphenytoin
Levetiracetam
Phenytoin
Piracetam
Criteria
Inclusion Criteria:

- age 18 or older

- patient presenting to Grady Memorial Hospital's Emergency Department after having a
tonic-clonic seizure (primary or secondarily generalized) within the last 4 hours

Cause of seizure for inclusion: reason for seizure is often undetermined at time of
presentation to the Emergency Department. The most likely expected causes of a seizure are
noncompliance to existing antiepileptic drug regimen, refractory epilepsy with breakthrough
seizure, metabolic aberration, alcohol withdrawal, or unknown.

Exclusion Criteria:

- non-English speaking

- first time seizure

- seizures other than tonic-clonic seizure (primary or secondarily generalized)

- more than 3 seizures in 24 hours or status epilepticus, pregnant patients by history
or by urine pregnancy testing, serious neurologic insult resulting in seizure but
where seizure is not the primary reason for admission (e.g. traumatic brain injury
with seizure or hemorrhagic stoke would be excluded)

- contraindication to IV levetiracetam

- received IV phenytoin within 24 hours

- known allergy to phenytoin

- previously enrolled in the study